PREDICTORS of clinical response in a double-blind placebo controlled crossover trial of gabapentin enacarbil for RESTLESS legs syndrome

Restless Legs Syndrome (RLS) is a sensory-motor disorder which produces sleep disturbance. Using data from a large clinical trial of gabapentin enacarbil (GEn) we sought to assess the ability of baseline, and changes from baseline, in clinical trial endpoints to predict treatment response.

https://ift.tt/2HP75kZ